These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 24391021

  • 1. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA, Rasch V, Iftner T, Kahesa C, Mwaiselage JD, Junge J, Gernow A, Ejlersen SF, Munk C, Kjaer SK.
    Int J Cancer; 2014 Aug 15; 135(4):896-904. PubMed ID: 24391021
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
    Baldur-Felskov B, Mwaiselage J, Faber MT, Kjaerem M, de la Cour CD, Munk C, Kahesa C, Iftner T, Rasch V, Kjaer SK.
    Trop Med Int Health; 2019 Feb 15; 24(2):229-237. PubMed ID: 30444556
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
    Dartell M, Rasch V, Kahesa C, Mwaiselage J, Ngoma T, Junge J, Gernow A, Ejlersen SF, Munk C, Iftner T, Kjaer SK.
    Sex Transm Dis; 2012 Mar 15; 39(3):201-8. PubMed ID: 22337107
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.
    J Med Screen; 2005 Mar 15; 12(3):142-9. PubMed ID: 16156945
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
    ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X.
    Int J Cancer; 1992 Jun 19; 51(4):515-21. PubMed ID: 1318265
    [Abstract] [Full Text] [Related]

  • 6. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A.
    BJOG; 2004 Aug 19; 111(8):842-8. PubMed ID: 15270934
    [Abstract] [Full Text] [Related]

  • 7. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
    Reddy D, Njala J, Stocker P, Schooley A, Flores M, Tseng CH, Pfaff C, Jansen P, Mitsuyasu RT, Hoffman RM.
    Int J STD AIDS; 2015 May 19; 26(6):379-87. PubMed ID: 24928579
    [Abstract] [Full Text] [Related]

  • 8. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Srisomboon J, Intaraphet S, Siriaunkgul S.
    PLoS One; 2016 May 19; 11(6):e0158184. PubMed ID: 27336913
    [Abstract] [Full Text] [Related]

  • 9. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 19; 18(1):321-30. PubMed ID: 19124515
    [Abstract] [Full Text] [Related]

  • 10. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E, Pedersen HN, Mitchell SM, Sekikubo M, Mwesigwa D, Singer J, Biryabarema C, Byamugisha JK, Money DM, Ogilvie GS.
    Trop Med Int Health; 2015 Oct 19; 20(10):1355-67. PubMed ID: 26031572
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C, Origoni M, Maillard M, Ferrari D, Ciuffreda D, Mastrorilli E, Lazzarin A, Lillo F.
    J Med Virol; 1998 Oct 19; 56(2):133-7. PubMed ID: 9746069
    [Abstract] [Full Text] [Related]

  • 12. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P, Bradford L, Manga S, Nulah K, Kiyang E, Manjuh F, DeGregorio G, Ogembo RK, Orock E, Liu Y, Wamai RG, Sheldon LK, Gona PN, Sando Z, Welty T, Welty E, Ogembo JG.
    Gynecol Oncol; 2018 Jan 19; 148(1):118-125. PubMed ID: 29153541
    [Abstract] [Full Text] [Related]

  • 13. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Kahesa C, Thomsen LT, Linde DS, Mchome B, Katanga J, Swai P, Manongi R, Kjaerem M, Iftner T, Waldstrøm M, Mwaiselage J, Rasch V, Kjaer SK.
    Int J Cancer; 2023 Feb 15; 152(4):686-696. PubMed ID: 36093587
    [Abstract] [Full Text] [Related]

  • 14. Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea.
    Toliman PJ, Kaldor JM, Badman SG, Gabuzzi J, Silim S, Kumbia A, Kombuk B, Kombati Z, Munnull G, Guy R, Vallely LM, Kelly-Hanku A, Wand H, Ryan C, Tan G, Brotherton J, Saville M, Mola GDL, Garland SM, Tabrizi SN, Vallely AJ.
    Papillomavirus Res; 2018 Dec 15; 6():70-76. PubMed ID: 30391365
    [Abstract] [Full Text] [Related]

  • 15. HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women.
    Mchome BL, Kjaer SK, Manongi R, Swai P, Waldstroem M, Iftner T, Wu C, Mwaiselage J, Rasch V.
    Sex Transm Infect; 2021 Feb 15; 97(1):56-62. PubMed ID: 32269071
    [Abstract] [Full Text] [Related]

  • 16. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T, Dube Mandishora R, Borok M.
    Intervirology; 2019 Feb 15; 62(2):90-95. PubMed ID: 31412350
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
    Holt HK, Zhang L, Zhao FH, Hu SY, Zhao XL, Zhang X, Pan QJ, Zhang WH, Smith JS, Qiao YL.
    Int J Cancer; 2017 Feb 01; 140(3):544-554. PubMed ID: 27727464
    [Abstract] [Full Text] [Related]

  • 18. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY, Qiao ZQ, Zhang MF, Yang JP, Bao YP, An YT, Lei J, Xiong NH, Yu XH, Zhang X, Pan QJ, Qiao YL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct 01; 28(10):964-7. PubMed ID: 18399140
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
    Pimple S, Shastri SS.
    Indian J Cancer; 2014 Oct 01; 51(2):117-23. PubMed ID: 25104191
    [Abstract] [Full Text] [Related]

  • 20. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES, Hong X, Crum CP, Feldman S.
    Gynecol Oncol; 2007 Mar 01; 104(3):702-6. PubMed ID: 17150245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.